Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-043405
Filing Date
2025-03-21
Accepted
2025-03-21 18:33:38
Documents
1
Period of Report
2020-04-20

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5427
  Complete submission text file 0000950170-25-043405.txt   8381
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Issuer) CIK: 0001468639 (see all company filings)

EIN.: 621153426 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SOLAR CAPITAL LLC 500 PARK AVENUE, 5TH FLOOR NEW YORK NY 10022
Business Address
Potter Leonard (Reporting) CIK: 0001476217 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56145 | Film No.: 25761859

Mailing Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Reporting) CIK: 0001582384 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1213
Type: 3 | Act: 34 | File No.: 000-56145 | Film No.: 25761861

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 817-871-4000
Wildcat Partner Holdings, LP (Reporting) CIK: 0001633223 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-56145 | Film No.: 25761860